Science & Enterprise subscription

Follow us on Twitter

  • AAAS report: US ranks 10th in R&D as share of GDP ... https://t.co/q8Pk5ZLxmV
    about 2 hours ago
  • Clinical trial results show a strategy that first tests for genomic mutations to guide treatments results in better… https://t.co/zUmOOX2ZDo
    about 6 hours ago
  • New post on Science and Enterprise: Better Precision Medicine Outcomes Shown for Leukemia https://t.co/nghNIBCxOP #Science #Business
    about 6 hours ago
  • Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody t… https://t.co/4N2k2fxKUd
    about 11 hours ago
  • New post on Science and Enterprise: Lilly, NIH Halt Covid-19 Antibody Therapy Trial https://t.co/l6PIHNlOEA #Science #Business
    about 12 hours ago

Please share Science & Enterprise

Infographic – Split U.S. Decision on Covid-19 Vaccine

Covid-19 vaccination poll

Click on image for full-size view (Statista)

15 Aug. 2020. While the U.S. government, drug makers, and biotech companies pour billions of dollars into vaccines against Covid-19 infections, a large percentage of the American public is still not ready to be vaccinated. Results from a recent Gallup Poll show one in three American adults (35%) would not get a Covid-19 vaccine, even if free and approved by the FDA.

The Gallup data, compiled by the business research company Statista, show two-thirds of U.S. respondents (65%) would agree to be vaccinated against Covid-19. Younger, urban, and White Americans are somewhat more likely to get the vaccine than their older, rural, and non-White counterparts. But the greatest predictor is political affiliation: eight in 10 Democratic respondents (81%) would get the vaccine, while Republicans are divided about evenly — 47 percent say yes, while 53 percent say no.

Gallup asked the question 20 July to 2 Aug. of 7,632 adults, aged 18 and older, taking part in the Gallup Panel, recruited through probability-based random methods.

Poll questions of this kind are, of course, speculative, since Covid-19 vaccines in Western countries are only now reaching late-stage, large-scale clinical trials. Yet the responses indicate the need for a large-scale education campaign and public health policies encouraging the public to get vaccinated.

More from Science & Enterprise:

*     *     *

1 comment to Infographic – Split U.S. Decision on Covid-19 Vaccine